| abstract |
Provided are a phenylalanine compound having a nitrogen heterocyclic link that can substantially lower blood sugar and regulate glycolipid metabolic activity, pharmaceutically acceptable salts or stereoisomers thereof, pharmaceutical compositions having the compound, and the use of the compound in preparing medicines for diabetics and glycolipid metabolic disorders, in particular, the use thereof in preparing medicines for treating type II diabetes. The compound has a structure as presented in formula I. |